Back to Search Start Over

Summary of in vivo studies from Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts

Authors :
Alana L. Welm
Jean-Paul De La O
Najme Faham
Parvathi Radhakrishnan
Magdalena Bieniasz
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Summary of in vivo studies

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....183912a4bbb9ffbe64d5708a7e81ecc7